Overview
Aridol is an indirect, standardised, dose-responsive test kit containing everything required to complete a bronchial challenge test.
- Indication
- Identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma
- Uses
- Diagnosing bronchial hyperresponsiveness. Exercise-induced asthma. Occupational asthma. Assessing and monitoring response to inhaled corticosteroids.
- Manufacturer
- Pharmaxis Ltd, Frenchs Forest, Sydney
- Distributor in Australia
- BTC Speciality Health Pty Ltd
The mannitol challenge test
The mannitol challenge test is an indirect osmotic bronchial challenge test that can be used to identify bronchial hyperresponsiveness, a key clinical feature of respiratory conditions such as asthma. Aridol is supplied as a standardised test kit containing pre-filled mannitol capsules and a hand-held dry powder inhaler.
During the test, the subject inhales increasing doses of mannitol, with their lung function (forced expiratory volume in one second, FEV1) measured after each dose to determine the level of bronchial hyperresponsiveness.
The mannitol challenge test should only be performed by a suitably trained healthcare professional. Refer to the approved Product Information before performing this challenge test.
Order codes
| Factory Code | Australia Order Code | NZ Order Code | Description |
|---|---|---|---|
| 400128 | CH2 2599029 | N/a | ARIDOL® (mannitol) Kit (1 single kit) |
Ordering and support
How to order
- Phone
- 1300 720 274
- Fax
- 1300 364 008
- hospital@ch2.net.au
- Hours
- 8am to 6pm AEST, 8am to 5pm WA time
Medical information and adverse events
- Phone
- 1800 100 282 or +61 404 869 472
BTC Speciality Health Pty Ltd, Level 1, 10 Oxley Road, Hawthorn VIC 3122.
